Blue Ridge Capital’s Adient ADNT Stock Holding History

Blue Ridge Capital’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,190,000	Closed	-$93.7M	–	1
2017 Q4	$93.7M	Sell	1,190,000 -770,000	-39%	-$62.1M	3.12%	13
2017 Q3	$165M	Sell	1,960,000 -400,300	-17%	-$28.4M	2.96%	16
2017 Q2	$154M	Buy	+2,360,300	New	+$161M	2.7%	16

Other funds holding ADNT

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Blue Ridge Capital's ADNT Position: Q1 2018 in Review

Blue Ridge Capital sold out of Adient (ADNT) in Q1 2018, closing a stake of 1,190,000 shares — an estimated $93.7M sold.

Blue Ridge Capital first reported a position in ADNT in Q2 2017 and held it in 3 quarters. The position peaked at $165M in Q3 2017. 402 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

Blue Ridge Capital reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
Blue Ridge Capital sold 1,190,000 Adient shares in Q1 2018, an estimated $93.7M.
Blue Ridge Capital first reported a position in Adient in Q2 2017 and held it in 3 quarters.
Blue Ridge Capital's Adient position peaked at $165M in Q3 2017.
402 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Blue Ridge Capital's 13F filing for Q1 2018.